🇺🇸 FDA
Patent

US 11129903

Multispecific antigen-binding molecules and uses thereof

granted A61KA61K2039/507A61K2039/572

Quick answer

US patent 11129903 (Multispecific antigen-binding molecules and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Sep 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K2039/507, A61K2039/572, A61K47/68033, A61K47/6849